The 2nd edition of the Nanomedicine Award aims to reward projects that have developed innovative solutions based on nanomedicine that can ultimately change the way diseases are treated or diagnosed and that could provide new tools for physicians and large benefits to patients.

Open to companies, academic and private researchers from European and non-European countries, the Nanomedicine Award aims to honor the best international nanomedicine innovations. Proposals will be evaluated in two areas: Early clinical stage project Award and Best product / deal Award for application in diagnostic, therapeutic or regenerative medicine.

Award review board

All applications will be reviewed and assessed by a panel of highly-qualified pharma industry specialists with experience in R&D and commercial roles. The reviewers are:

  • Patrick Boisseau – Head of Business Development CEA, President of the ETPN
  • Patrick Tricoli – VP Corporate Dev & CEO Nanobiotix Corp.
  • Jeff Hrkach – formerly Chief Technology Officer of BIND Therapeutics, Inc and member of the Nanomedicines Alliance
  • Henry Havel – former Senior Research Fellow at Eli Lilly and Chairman of the Nanomedicines Alliance

The Organizers and the Award Ceremony

The European Technology Platform for Nanomedicine (ETPN) together with an EU funded consortium named ENATRANS are organizing the second edition of the Nanomedicine Award.

Further information can be found here and on the ETPN website

The Nanomedicine Award is supported by EBD Group and the award ceremony will take place during BIO-Europe® 2015. The 21th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Over 3,200 international decision makers from biotech, pharma and finance along with the most promising start-ups and emerging companies, representing upwards of 1,800 companies, annually attend BIO-Europe® to identify new business opportunities and develop strategic relationships. BIO-Europe® features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe® will take place November 2-4, 2015 in Munich, Germany.

To learn more visit the BIO-Europe® website